Si-Bone (SIBN) FCF Margin Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1,716.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,811.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,833.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 192.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 261.00 |
| 10 | Si-Bone | 611.92 Mn | 471.80 Mn | 41.94 Mn | 928.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 928.00 |
| Dec 31, 2025 | -1,476.00 |
| Sep 30, 2025 | 2,212.00 |
| Jun 30, 2025 | 1,640.00 |
| Mar 31, 2025 | 1,073.00 |
| Dec 31, 2024 | 2,489.00 |
| Sep 30, 2024 | -2,556.00 |
| Jun 30, 2024 | 505.00 |
| Mar 31, 2024 | 1,527.00 |
| Dec 31, 2023 | -676.00 |
| Sep 30, 2023 | 4,732.00 |
| Jun 30, 2023 | 4,690.00 |
| Mar 31, 2023 | 2,959.00 |
| Dec 31, 2022 | 5,040.00 |
| Sep 30, 2022 | -1,312.00 |
| Jun 30, 2022 | -1,912.00 |
| Mar 31, 2022 | -1,490.00 |
| Dec 31, 2021 | -1,125.00 |
| Sep 30, 2021 | 1,001.00 |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | 47.00 |
| Dec 31, 2020 | 1,038.00 |
| Sep 30, 2020 | 1,351.00 |
| Jun 30, 2020 | -63.00 |
| Mar 31, 2020 | -778.00 |
| Dec 31, 2019 | -343.00 |
| Sep 30, 2019 | -3,017.00 |
| Jun 30, 2019 | -4,772.00 |
| Mar 31, 2019 | -1,173.00 |
| Dec 31, 2018 | -1,614.00 |